Výsledky vyhledávání

Akademický článek

Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases.

Autor: Chia DKA; Department of Surgery, University Surgical Cluster, National University Health System, Singapore, Singapore., Sundar R; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; The N.1 Institute for Health, National University of Singapore, Singapore, Singapore., Kim G; Department of Surgery, University Surgical Cluster, National University Health System, Singapore, Singapore., Ang JJ; Department of Surgery, University Surgical Cluster, National University Health System, Singapore, Singapore., Lum JHY; Department of Pathology, National University Hospital, National University Health System, Singapore, Singapore., Nga ME; Department of Pathology, National University Hospital, National University Health System, Singapore, Singapore., Goh GH; Department of Pathology, National University Hospital, National University Health System, Singapore, Singapore., Seet JE; Department of Pathology, National University Hospital, National University Health System, Singapore, Singapore., Chee CE; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore., Tan HL; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore., Ho J; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore., Ngoi NYL; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore., Lee MXW; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore., Muthu V; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore., Chan GHJ; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore., Pang ASL; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore., Ang YLE; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore., Choo JRE; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore., Lim JSJ; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore., Teh JL; Department of General Surgery, Ng Teng Fong General Hospital, Singapore, Singapore., Lwin A; Department of General Surgery, Ng Teng Fong General Hospital, Singapore, Singapore., Soon Y; Department of General Surgery, Ng Teng Fong General Hospital, Singapore, Singapore., Shabbir A; Department of Surgery, University Surgical Cluster, National University Health System, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Division of Surgical Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore., So JBY; Department of Surgery, University Surgical Cluster, National University Health System, Singapore, Singapore. jimmyso@nus.edu.sg.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. jimmyso@nus.edu.sg.; Division of Surgical Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore. jimmyso@nus.edu.sg., Yong WP; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.

Publikováno v: Annals of surgical oncology [Ann Surg Oncol] 2022 Dec; Vol. 29 (13), pp. 8597-8605. Date of Electronic Publication: 2022 Sep 07.

Zobrazit plný text záznamu

Akademický článek

Immune checkpoint inhibitor use and the incidence of hepatitis B virus reactivation or immune-related hepatitis in non-small cell lung cancer patients with chronic hepatitis B.

Autor: Hong J; Division of Hematology-Oncology, Department of Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Gyeonggi, Korea., Lee J; Lung Cancer Center, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea., Park S; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Jung HA; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Sun JM; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Lee SH; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Ahn JS; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Sinn DH; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea., Ahn MJ; Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Publikováno v: Cancer [Cancer] 2024 May 01; Vol. 130 (9), pp. 1693-1701. Date of Electronic Publication: 2024 Jan 02.

Zobrazit plný text záznamu